Literature DB >> 20333275

Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis.

Marzia Perluigi1, Rukhsana Sultana, Giovanna Cenini, Fabio Di Domenico, Maurizio Memo, William M Pierce, Raffaella Coccia, D Allan Butterfield.   

Abstract

Numerous studies have shown that neuronal lipids are highly susceptible to oxidative stress including in those brain areas directly involved in the neurodegenerative process of Alzheimer's disease (AD). Lipid peroxidation directly damages membranes and also generates a number of secondary biologically active products (toxic aldehydes)that are capable of easily attacking lipids, proteins, and DNA. Accumulating evidence has demonstrated regionally increased brain lipid peroxidation in patients with AD; however, extensive studies on specific targets of lipid peroxidation-induced damage are still missing. The present study represents a further step in understanding the relationship between oxidative modification of protein and neuronal death associated with AD. We used a proteomics approach to determine specific targets of lipid peroxidation in AD brain, both in hippocampus and inferior parietal lobule, by coupling immunochemical detection of 4-hydroxynonenal-bound proteins with 2-D polyacrylamide gel electrophoresis and MS analysis. We identified 4-hydroxynonenal-bound proteins in the hippocampus and inferior parietal lobule brain regions of subjects with AD. The identified proteins play different biological functions including energy metabolism, antioxidant system, and structural proteins, thus impairing multiple molecular pathways. Our results provide further evidence for the role of lipid peroxidation in the pathogenesis of AD.

Entities:  

Year:  2009        PMID: 20333275      PMCID: PMC2843938          DOI: 10.1002/prca.200800161

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  65 in total

Review 1.  Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism.

Authors:  S Hoyer
Journal:  J Neural Transm Suppl       Date:  1998

2.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

Authors:  R S Frackowiak; C Pozzilli; N J Legg; G H Du Boulay; J Marshall; G L Lenzi; T Jones
Journal:  Brain       Date:  1981-12       Impact factor: 13.501

3.  Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction.

Authors:  M V Aksenova; M Y Aksenov; J M Carney; D A Butterfield
Journal:  Mech Ageing Dev       Date:  1998-01-30       Impact factor: 5.432

4.  Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

Authors:  Muthuswamy Anantharaman; Jitbanjong Tangpong; Jeffery N Keller; Michael P Murphy; William R Markesbery; Kelley K Kiningham; Daret K St Clair
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

Review 6.  Hydroxynonenal, toxic carbonyls, and Alzheimer disease.

Authors:  Quan Liu; Arun K Raina; Mark A Smith; Lawrence M Sayre; George Perry
Journal:  Mol Aspects Med       Date:  2003 Aug-Oct

7.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R Markesbery
Journal:  Neurobiol Dis       Date:  2006-02-08       Impact factor: 5.996

Review 8.  Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration.

Authors:  D Allan Butterfield; Debra Boyd-Kimball; Alessandra Castegna
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

9.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

Review 10.  Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

Authors:  Kathleen S Montine; Joseph F Quinn; Jing Zhang; Joshua P Fessel; L Jackson Roberts; Jason D Morrow; Thomas J Montine
Journal:  Chem Phys Lipids       Date:  2004-03       Impact factor: 3.329

View more
  76 in total

1.  Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis.

Authors:  Yang Lu; Xiaoluan Liu; Suozhu Shi; Huabin Su; Xueyuan Bai; Guangyan Cai; Fuquan Yang; Zhensheng Xie; Yunping Zhu; Yanqiong Zhang; Shujia Zhang; Xiaofan Li; Shan Wang; Di Wu; Li Zhang; Jie Wu; Yuansheng Xie; Xiangmei Chen
Journal:  Mol Cell Proteomics       Date:  2011-12-07       Impact factor: 5.911

Review 2.  Proteomic identification of carbonylated proteins and their oxidation sites.

Authors:  Ashraf G Madian; Fred E Regnier
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

3.  To tag or not to tag: a comparative evaluation of immunoaffinity-labeling and tandem mass spectrometry for the identification and localization of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation.

Authors:  Jia Guo; Laszlo Prokai
Journal:  J Proteomics       Date:  2011-07-30       Impact factor: 4.044

4.  Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.

Authors:  Renã A S Robinson; Gururaj Joshi; Quanzhen Huang; Rukhsana Sultana; Austin S Baker; Jian Cai; William Pierce; Daret K St Clair; William R Markesbery; D Allan Butterfield
Journal:  Proteomics       Date:  2011-09-22       Impact factor: 3.984

Review 5.  The Proteasome and Oxidative Stress in Alzheimer's Disease.

Authors:  Vicent Bonet-Costa; Laura Corrales-Diaz Pomatto; Kelvin J A Davies
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

Review 6.  Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Miranda L Bader Lange; Rukhsana Sultana
Journal:  Biochim Biophys Acta       Date:  2010-02-20

Review 7.  Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

8.  Neuroprotective Effects of Rhynchophylline Against Aβ1-42-Induced Oxidative Stress, Neurodegeneration, and Memory Impairment Via Nrf2-ARE Activation.

Authors:  Pan Jiang; Lei Chen; Jian Xu; Wenyuan Liu; Feng Feng; Wei Qu
Journal:  Neurochem Res       Date:  2021-06-25       Impact factor: 3.996

Review 9.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

Review 10.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.